Transforming Cancer Care: SAGA Diagnostics' Test Now Launched in the U.S.
Lao Saal and Anthony George, founders of SAGA Diagnostics SAGA Diagnostics, a portfolio company of LU Ventures, has the potential to transform cancer care by detecting cancer recurrence early with unparalleled sensitivity. Founded in 2016 from research in Lund, their groundbreaking test is now available in the U.S. From Lab to Life: The Research Behind SAGA's BreakthroughThere's a significant need
https://www.innovation.lu.se/en/article/transforming-cancer-care-saga-diagnostics-test-now-launched-us - 2025-08-27